Global Health Q2 FY27 Revenue Up 33.6% to ₹14,690 Million
Global Health Limited announced its unaudited consolidated financial results for the second quarter and half year ended September 30, 2026. Revenue from operations surged by 33.6% year-on-year to INR 14,690 million in Q2 FY27. Operating EBITDA grew by 60.2% year-on-year to INR 3,701 million, with margins improving to 25.2% from 21.0% in Q2 FY26. Profit after tax increased by 38.3% year-on-year to INR 2,191 million. The company added 74 new beds across its network during the quarter, with Noida hospital achieving EBITDA breakeven. The board also approved the development of a new ~500-bedded super-specialty hospital in Ghaziabad.
Key Highlights
- Q2 FY27 revenue from operations increased by 33.6% YoY to INR 14,690 million.
- Operating EBITDA grew 60.2% YoY to INR 3,701 million, with margins at 25.2%.
- Profit after tax rose 38.3% YoY to INR 2,191 million.
- 74 new beds added; Noida hospital achieved EBITDA breakeven.
- Board approved a new ~500-bedded hospital in Ghaziabad.
Price Impact
More from MEDANTA
Global Health Approves ₹997 Cr Ghaziabad Hospital Project
Global Health Approves Q2 FY27 Financial Results & ₹997 Cr Hospital Project
Medanta Q2 FY27: consolidated PAT +38% YoY (~54% adjusted), revenue +34%, margins widen